[Federal Register Volume 87, Number 55 (Tuesday, March 22, 2022)]
[Notices]
[Pages 16217-16218]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-D-3462]


Verification Systems Under the Drug Supply Chain Security Act for 
Certain Prescription Drugs; Draft Guidance for Industry; Correction

AGENCY: Food and Drug Administration, Department of Health and Human 
Services (HHS).

[[Page 16218]]


ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
entitled ``Verification Systems Under the Drug Supply Chain Security 
Act for Certain Prescription Drugs; Draft Guidance for Industry'' that 
appeared in the Federal Register of March 10, 2022. The document 
omitted the date by which comments on the draft guidance should be 
submitted to FDA. This error is corrected in this document for clarity.

FOR FURTHER INFORMATION CONTACT: Sarah Venti, Office of Compliance, 
Center for Drug Evaluation and Research, Food and Drug Administration, 
10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-3130, 
[email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of March 10, 2022 
(87 FR 13738), appearing on page 13738, in FR Doc. 2022-05018, in the 
second column, the DATES section is corrected to read as follows:

DATES: The announcement of the guidance is published in the Federal 
Register on March 10, 2022. Although you can comment on any guidance at 
any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency considers 
your comment on this draft guidance before it begins work on the final 
version of the guidance, submit either electronic or written comments 
on the draft guidance by May 9, 2022.

    Dated: March 17, 2022.
Andi Lipstein Fristedt,
Deputy Commissioner for Policy, Legislation, and International Affairs, 
U.S. Food and Drug Administration.
[FR Doc. 2022-06006 Filed 3-21-22; 8:45 am]
BILLING CODE 4164-01-P